P3 Health Partners PIII
P3 Health Partners reports $15.62 million net income for Q3 2026
P3 Health Partners (PIII) filed a 10-Q with the SEC on Nov 9, 2026, 4:46 pm ET. Source: the filing on SEC EDGAR.
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0001832511-26-000046
- Revenue of $396.34 million for the three months ended Sep 30, 2026
- Net income of $15.62 million for the three months ended Sep 30, 2026
- Diluted EPS of $0.07 for the three months ended Sep 30, 2026
- Cash and equivalents of $43.9 million as of Sep 30, 2026
Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.
Going-concern warning repeated
“As a result of these matters, substantial doubt exists about the Company's ability to continue as a going concern for one year after the date the financial statements are issued.”
Also in the prior 10-Q (filed Aug 10, 2026). Prior report Prior on EDGAR
Quoted from the filing.
What changed since last quarter
No new risk factors or legal mentions.
Compared with the 10-Q for the period ended Jun 30, 2026.
| This filing | Previous | Change vs prior 10-Q | |
|---|---|---|---|
| Revenue | $396.34M | $386.38M | +2.6% |
| Operating income and margin | $22.98M · 5.8% | $41.23M · 10.7% | −44%, margin −4.9 pts |
| Net income | $15.62M | $7.44M | +110% |
| Operating cash flow | −$685K | −$61.91M | +99% |
| Cash | $43.9M | $21.27M | +106% |
